Technology | January 13, 2015

Viztek Announces FDA Approval of Exa PACS

First PACS to Enable Zero Footprint Full-Featured Diagnostic Viewing

PACS, Remote Viewing Systems, RSNA 2015, Exa PACS, EHR PACS

Image courtesy of Viztek

January 13, 2015 — Viztek announced the U.S. Food and Drug Administration (FDA) approval of its Exa PACS. Completely web-based and compatible with all devices and operating systems, the Exa PACS delivers efficiency and productivity benefits to hospitals, imaging centers and teleradiology groups via PACS accessibility and utility for end users.

Exa's zero footprint technology allows the viewer to be fully operational within a web browser, eliminating the requirement to install additional programs that traditional viewers need. Viztek was the first PACS provider to license the zero footprint technology. Server-side rendering allows for physicians to bypass the delays of prefetching or auto-routing to instantaneously open large studies, which enables a faster, streamlined workflow and provides physicians with immediate access from any location with full diagnostic quality viewing and advanced utility, with nearly any level of Internet connection.

While the diagnostic benefits are key for radiologists, Exa also provides significant benefits for the IT department. In hospital settings, where radiology departments commonly rely on 1000-slice CT, digital mammography and other modalities generating significant files sizes of 600 MB and larger, the relief provided via Exa is substantial and cost-effective. The server-side rendering of the PACS eliminates the need for radiology departments to transfer large data sets around, significantly reducing strain on the greater hospital network while alleviating organizations from the costs of needing to bolster their networks.

The Viztek Exa PACS works in tandem with the Exa EHR, which has bundled all essential components of the radiology workflow process including PACS, practice management, billing, order entry, radiology reports, patient portals and other software product currently delivered by the company.  

For more information: www.viztek.net

Related Content

MaineHealth Selects eUnity Platform for Clinical and Diagnostic Viewing
News | Enterprise Imaging | August 17, 2017
August 17, 2017 — Client Outlook recently announced that MaineHealth has selected eUnity as its...
ScImage Awarded U.S. Government DIN-PACS IV Contract
News | PACS | August 16, 2017
ScImage Inc. was recently awarded a new DIN-PACS IV (Digital Imaging Network/Picture Archiving and Communications...
Carestream Launches MR Brain Perfusion and Diffusion Modules for Vue PACS
Technology | Advanced Visualization | August 16, 2017
Carestream Health recently introduced new MR (magnetic resonance) Brain Perfusion and MR Brain Diffusion modules that...
Neighbors Emergency Center Selects Novarad PACS/RIS
News | PACS | August 15, 2017
August 15, 2017 — Novarad Corp.
Fujifilm Launches Synapse PACS Version 5
Technology | PACS | August 03, 2017
August 3, 2017 – Fujifilm Medical Systems U.S.A. Inc.
RamSoft has teamed up with Availity to bring healthcare providers Patient Access and Patient Authorizations
News | PACS | July 31, 2017
RamSoft has teamed up with Availity to bring healthcare providers Patient Access and Patient Authorizations, two fully...
Agfa Receives FDA 510(k) for Xtend Functionalities on Xero Universal Viewer
Technology | Remote Viewing Systems | July 27, 2017
Agfa HealthCare announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Xero Xtend...
News | Enterprise Imaging | July 24, 2017
July 24, 2017 — Insignia Medical Systems has been selected to supply three National Health Service (NHS) Trusts worki
TomTec Unveils TomTec Zero Cardiovascular Viewing Software
Technology | Remote Viewing Systems | July 24, 2017
July 24, 2017 — TomTec Zero is the latest addition to the TomTec portfolio.
Philips Receives FDA 510(k) Clearance for IntelliSpace Portal 9.0
Technology | Advanced Visualization | June 29, 2017
Philips announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market...
Overlay Init